[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 20, 2011

Time to Take Health Delivery Research Seriously

Author Affiliations

Author Affiliations: Department of Surgery (Dr Pronovost), and Department of Anesthesiology and Critical Care Medicine, Quality and Safety Research Group, Johns Hopkins University School of Medicine, Baltimore, Maryland (Drs Pronovost and Goeschel); Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health (Drs Pronovost and Goeschel); and Johns Hopkins University School of Nursing (Drs Pronovost and Goeschel).

JAMA. 2011;306(3):310-311. doi:10.1001/jama.2011.1015

Biomedical science has made amazing life-saving discoveries. The science of “omics” offers hope for further improvements in preventing, prognosticating, and personalizing care. Each year, researchers publish approximately 18 000 active clinical trials,1 yet a gap remains between the development and publication of this new knowledge and better patient outcomes. While clinical translational science awards strive to improve population health, their predominant focus has been on translating basic research findings to humans. Although this Commentary focuses on preventable harm within the health care system, the principles discussed likely apply to optimizing population health using a broader set of public health interventions.

First Page Preview View Large
First page PDF preview
First page PDF preview